Betz Stephen F. — SEC insider filings
SEC reporting owner CIK 1886575. 57 insider filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers the 50 most recent of 57 filings on record, filed 2021-12-30 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 44 legs across 41 filings — 251,773 shares, $7,564,869 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: sale of 97,483 shares @ $32.23 ($3,141,877) in Crinetics Pharmaceuticals, Inc., filed 2025-06-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | 50 | — | 44 legs · 251,773 sh · $7,564,869 | 34 |
Insider filings — Betz Stephen F.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to issuer (D): 58,286 @ $85 · Disposition to issuer (D): 79,650 @ $85 · Disposition to issuer (D): 90,514 (derivative) @ $83.09 · Disposition to issuer (D): 74,540 (derivative) @ $75.72 · Disposition to issuer (D): 56,250 (derivative) @ $59.81 · Disposition to issuer (D): 60,000 (derivative) @ $62.39 · +7 more | EDGAR |
| 2026-03-18 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 6,371 @ $37.11 · Sale (S): 4,241 @ $37.77 | EDGAR |
| 2026-02-25 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 47,000 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 18,000 @ $1.91 · Option exercise (M): 18,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 71,525 @ $1.91 · Option exercise (M): 16,645 @ $9.28 · Sale (S): 97,483 @ $32.23 · Option exercise (M): 71,525 (derivative) @ $0 · Option exercise (M): 16,645 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 5,479 @ $34.17 · Sale (S): 291 @ $34.83 | EDGAR |
| 2025-02-24 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 43,000 @ $0 · Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 2,331 @ $1.91 · Option exercise (M): 2,331 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 1,035 @ $51.50 | EDGAR |
| 2024-08-28 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $53.19 | EDGAR |
| 2024-08-14 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $47.68 | EDGAR |
| 2024-07-26 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $53.43 | EDGAR |
| 2024-07-12 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $48.55 | EDGAR |
| 2024-06-26 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $45.37 | EDGAR |
| 2024-06-11 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $43.86 | EDGAR |
| 2024-05-30 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $47.49 | EDGAR |
| 2024-05-14 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $49.43 | EDGAR |
| 2024-03-20 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Tax withholding (F): 3,655 @ $38.14 | EDGAR |
| 2024-03-06 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 23,000 @ $0 · Grant/award (A): 87,000 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $37.26 | EDGAR |
| 2024-01-12 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $37.65 | EDGAR |
| 2023-12-27 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $35.89 | EDGAR |
| 2023-12-13 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $32.87 | EDGAR |
| 2023-11-29 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $31.84 | EDGAR |
| 2023-03-17 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Tax withholding (F): 1,410 @ $17.12 | EDGAR |
| 2023-03-03 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 23,600 @ $0 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2023-02-03 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,126 @ $19.59 | EDGAR |
| 2023-01-27 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 8,336 @ $21.07 | EDGAR |
| 2023-01-19 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,126 @ $18 | EDGAR |
| 2023-01-05 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,126 @ $18.35 | EDGAR |
| 2022-12-19 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,126 @ $16 | EDGAR |
| 2022-12-05 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,126 @ $17.84 | EDGAR |
| 2022-11-17 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,126 @ $18.72 | EDGAR |
| 2022-11-03 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,126 @ $18.52 | EDGAR |
| 2022-10-19 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,126 @ $17.73 | EDGAR |
| 2022-10-05 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,126 @ $19.64 | EDGAR |
| 2022-09-19 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 4,168 @ $21.01 | EDGAR |
| 2022-09-09 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 1,042 @ $21.00 | EDGAR |
| 2022-09-06 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Other (J): 1,336 @ $11.02 · Sale (S): 3,126 @ $18.59 | EDGAR |
| 2022-05-04 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,247 @ $20.10 | EDGAR |
| 2022-04-21 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 5,664 @ $25.81 | EDGAR |
| 2022-04-06 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 9,000 @ $23.97 | EDGAR |
| 2022-04-01 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 4,164 @ $21.06 · Sale (S): 4,164 @ $21.80 | EDGAR |
| 2022-03-17 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,123 @ $18.94 | EDGAR |
| 2022-03-02 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 16,500 @ $0 · Sale (S): 3,123 @ $19.73 · Grant/award (A): 77,000 (derivative) @ $0 | EDGAR |
| 2022-02-17 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,123 @ $18.64 | EDGAR |
| 2022-02-03 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,123 @ $18.79 | EDGAR |
| 2022-01-20 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 4,168 @ $23.29 | EDGAR |
| 2022-01-06 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 7,168 @ $28.02 | EDGAR |
| 2021-12-30 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $27.95 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-10-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1886575 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs